The abilities of golimumab in the therapy of ankylosing spondylitis

The paper summarizes the data of the GO-RAISE trial evaluating the efficacy and tolerability of golimumab (GLM) in patients with ankylosing spondylitis (AS). The trial was launched in 57 clinical centers of North America, Europe, and Asia in 2005. It enrolled 356 patients with high AS activity (BASD...

Full description

Bibliographic Details
Main Author: Sh. F. Erdes
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2014-09-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/565